Subscribe

Pricing

C. Daniel Mullins, PhD, talks about the importance of considering the value equation when it comes to treating oncology patients. Oncologists should have conversations with their patients about clinical effectiveness and affordability in order to determine the best course of treatment. This approach is more challenging, but leads to more patient-centered care.
Dr. Mullins emphasizes that the role of oncologists is changing, and they should recognize that treatment cost is an important consideration for patients. Having cost information available for patients is one way oncologists can help patients make decisions about their care.
According to Dr. Mullins, patients are having new conversations with their physicians about the cost of care and their ability to pay for treatment. He points out that some patients are not taking their medications because they cannot afford them, and says that social services need to be established to help these individuals.
Andrew Stainthorpe, PhD, PASLU, NICE, talks about why the FDA should not take drug cost into account when weighing the approval of expensive medications.
Dr. Stainthorpe sheds light on the value-based concerns of oncologists in Europe, which include patient benefit, low side effects, and treatment options.
According to Dr. Stainthorpe, the cost of care can be alleviated for patients and providers using imaginative reimbursement approaches such as risk shares and managed entry schemes that pay by outcomes.
Linda Bosserman, MD, FACP, talks about the value-based concerns of physicians in the US, including outcomes, survival, toxicity, and cost to patient.
Dr. Bosserman explains that physicians must take cost and outcomes into consideration when evaluating treatment options.
In this segment Dr. Kolodziej explains how we ask patients to participate in a value based fashion can be a really tricky.
Dr. Kolodziej talks about the importance in price transparency, education on outcomes and involvment in shared decision making
Page 1 of 2
Results 1 - 10 of 15
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology